310 related articles for article (PubMed ID: 25037800)
1. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.
Reyes-Habito CM; Roh EK
J Am Acad Dermatol; 2014 Aug; 71(2):203.e1-203.e12; quiz 215-6. PubMed ID: 25037800
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: Part II. Targeted therapy.
Reyes-Habito CM; Roh EK
J Am Acad Dermatol; 2014 Aug; 71(2):217.e1-217.e11; quiz 227-8. PubMed ID: 25037801
[TBL] [Abstract][Full Text] [Related]
3. Drug eruptions associated with tumor therapy: Great imitators.
Ludwig C; Goh V; Rajkumar J; Au J; Tsoukas M
Clin Dermatol; 2020; 38(2):208-215. PubMed ID: 32513400
[TBL] [Abstract][Full Text] [Related]
4. [Hypersensitivity reactions to chemotherapeutic antineoplastic agents].
Rossi F; Incorvaia C; Mauro M
Recenti Prog Med; 2004 Oct; 95(10):476-81. PubMed ID: 15560295
[TBL] [Abstract][Full Text] [Related]
5. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
Jogi R; Garman M; Pielop J; Orengo I; Hsu S
J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
[TBL] [Abstract][Full Text] [Related]
6. Bendamustine-induced "flagellate dermatitis".
Mahmoud BH; Eide MJ
Dermatol Online J; 2012 Nov; 18(11):12. PubMed ID: 23217953
[TBL] [Abstract][Full Text] [Related]
7. [Nephrotoxicity of antineoplastic drugs].
Suzuki T; Nosaka K
Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
[No Abstract] [Full Text] [Related]
8. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
9. Flagellate Dermatitis in a Child Most Likely Secondary to Doxorubicin.
Lim D; Aussedat M; Maillet-Lebel N; Marcoux D
Pediatr Dermatol; 2017 Sep; 34(5):e257-e259. PubMed ID: 28804924
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
Pai VB; Nahata MC
Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury due to cancer chemotherapeutic agents.
Bahirwani R; Reddy KR
Semin Liver Dis; 2014 May; 34(2):162-71. PubMed ID: 24879981
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous reaction associated with weekly docetaxel administration.
Chew L; Chuen VS
J Oncol Pharm Pract; 2009 Mar; 15(1):29-34. PubMed ID: 18753180
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin-induced hyperpigmentation and hypersensitivity reactions to etoposide and vinblastine in a child with endodermal sinus tumor.
Mutafoğlu-Uysal K; Sarialioğlu F; Olgun N
Turk J Pediatr; 2001; 43(2):172-4. PubMed ID: 11432501
[TBL] [Abstract][Full Text] [Related]
14. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
15. Cancer chemotherapy.
Med Lett Drugs Ther; 1978 Sep; 20(19):81-8. PubMed ID: 683126
[No Abstract] [Full Text] [Related]
16. The cardiotoxicity of chemotherapeutic drugs.
Allen A
Semin Oncol; 1992 Oct; 19(5):529-42. PubMed ID: 1411651
[No Abstract] [Full Text] [Related]
17. Bleomycin-induced flagellate dermatitis.
Vuerstaek JD; Frank J; Poblete-Gutiérrez P
Int J Dermatol; 2007 Nov; 46 Suppl 3():3-5. PubMed ID: 17973877
[TBL] [Abstract][Full Text] [Related]
18. Flagellate pigmentation: a unique adverse effect of bleomycin therapy.
Al-Khenaizan S; Al-Berouti B
Eur J Dermatol; 2011; 21(1):146. PubMed ID: 21282096
[No Abstract] [Full Text] [Related]
19. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
Sibaud V; Fricain JC; Baran R; Robert C
Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin-Induced Flagellate Hyperpigmentation.
Wei KY; Wang SH; Ho CL
J Emerg Med; 2016 Sep; 51(3):e59-60. PubMed ID: 27372378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
